Results 21 to 30 of about 3,398,749 (331)

Budget Impact analysis of a new system of care in Parkinson’s disease patients

open access: yesGlobal & Regional Health Technology Assessment, 2022
Objective: To estimate the economic impact of the introduction of a new care system based on apomorphine and Patient Support Program for motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by
Chiara Bini   +4 more
doaj   +1 more source

Economic Evaluation Plan (EEP) for A Very Early Rehabilitation Trial (AVERT): An international trial to compare the costs and cost-effectiveness of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset with usual stroke unit care [PDF]

open access: yes, 2016
Rationale: A key objective of A Very Early Rehabilitation Trial is to determine if the intervention, very early mobilisation following stroke, is cost-effective.
Fiona Ellery   +9 more
core   +1 more source

Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia

open access: yesGlobal & Regional Health Technology Assessment, 2020
Introduction: Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) include all complicated skin and soft tissue infections. The aim of this study was to conduct a cost-utility analysis to compare dalbavancin with standard antibiotic therapies for
Andrea Marcellusi   +4 more
doaj   +1 more source

Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial) [PDF]

open access: yes, 2018
Introduction: Children who have experienced abuse and neglect are at increased risk of mental and physical health problems throughout life. This places an enormous burden on individuals, families and society in terms of health services, education, social
Boyd, Kathleen A.   +6 more
core   +2 more sources

Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre

open access: yesThe Journal of Headache and Pain, 2019
Background Migraine is one of the most common neurological diseases and an estimated 1.04 billion people worldwide have been diagnosed with migraine. Available data suggest that migraine is world widely associated with a high economic burden, but there ...
Andrea Negro   +5 more
doaj   +1 more source

Evaluating megaprojects: from the “iron triangle” to network mapping [PDF]

open access: yes, 2014
Evaluation literature has paid relatively little attention to the specific needs of evaluating large, complex industrial and infrastructure projects, often called ‘megaprojects’.
Altshuler A   +13 more
core   +1 more source

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Seasonal influenza is caused by two subtypes of influenza A and two lineages of influenza B. Although trivalent influenza vaccines (TIVs) contain both circulating A strains, they contain only a single B-lineage strain. This can lead to mismatches between
Francesco Saverio Mennini   +4 more
doaj   +1 more source

Evaluation of epidemiological and economic consequences due to the delay in treatment of hiv-positive patients caused by the covid-19 pandemic

open access: yesGlobal & Regional Health Technology Assessment, 2021
Objective: To assess, from an epidemiological and economic point of view, the consequences of the reduction in the supply of antiretroviral drugs due to the COVID-19 pandemic.
Andrea Marcellusi   +4 more
doaj   +1 more source

Economic evaluation: what does a nurse manager need to know?

open access: yes, 2005
This paper considers how health economists can assist nurse managers, using the concepts and tools of economic evaluation. We aim to clarify these and also explode some of the myths about economic evaluation and its role in health care decision-making ...
Douglas, Hannah-Rose, Normand, Charles
core   +1 more source

Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections

open access: yesGlobal & Regional Health Technology Assessment, 2023
Objective: The objective of this analysis was to evaluate the cost-effectiveness of imipenem/cilastatin/relebactam compared to colistin-imipenem in the treatment of hospitalized patients with Gram-negative bacterial infections caused by imipenem ...
Martina Paoletti   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy